None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged between 19 and 64 years old 2. Those who agree to participate in this study and voluntarily sign this study 3. Those whose VAS(visual analog scale) of knee joint pain is 40 or higher
Exclusion criteria
Exclusion criteria: 1. Those who have skin allergies or abnormal reactions to sunlight 2. Those with other chronic diseases (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results. 3. Those who have a skin wound on the affected knee and are at risk of infection 4. Patients with malignant tumors (can participate if no recurrence occurs within 5 years after completion of treatment) 5. Those currently taking steroids (prednisolone, methylprednisolone, betamethasone, dexamethasone, hydrocortisone, etc.), immunosuppressants (calcineurin inhibitors (cycloproline, tacrolimus), mTOR inhibitors (sharolimus, everolimus), antimetabolites (mycophenolate), drugs for mental illness (antidepressants (lorazepam, alprazolam, sertraline), anti-anxiety drugs (benzodiazepines, buspirone), etc.) or other drugs that may affect the results of the study. 6. Those who have participated in clinical trials for the treatment of knee joint pain within the past 3 months 7. Pregnant or breastfeeding 8. Those who participated in another clinical study and received intervention within 4 weeks of the screening visit of this study 9. Those who have difficulty filling out the consent form to participate in research 10. Other people who, in the opinion of the researcher, find it difficult to participate in clinical research 11. Those who have had knee surgery within 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knee joint pain VAS(Visual Analogue Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Western Ontario and McMaster Universities Index;EuroQoL 5-Dimension 5-Level;Convenience evaluation | — |
Countries
Korea, Republic of
Contacts
Cheonan Korean Medicine Hospital of Daejeon University